Keeping track of the SARS-CoV-2 vaccine pipeline

Edward P K Parker; Madhumita Shrotri; Beate Kampmann

doi:10.1038/s41577-020-00455-1

Keeping track of the SARS-CoV-2 vaccine pipeline

Nat Rev Immunol. 2020 Nov;20(11):650. doi: 10.1038/s41577-020-00455-1.

Authors

Edward P K Parker¹, Madhumita Shrotri², Beate Kampmann^{2

3}

Affiliations

¹ The Vaccine Centre, London School of Hygiene & Tropical Medicine, London, UK. edward.parker@lshtm.ac.uk.
² The Vaccine Centre, London School of Hygiene & Tropical Medicine, London, UK.
³ Vaccines & Immunity Theme, MRC Unit, The Gambia at the London School of Hygiene & Tropical Medicine, London, UK.

Abstract

This Web Watch introduces the VaC tracker, a web resource that features an overview of the COVID-19 ‘vaccine landscape’, a clinical trials database and a ‘living review’ that distils the results of vaccine trials as they become available.

MeSH terms

Betacoronavirus / drug effects
Betacoronavirus / immunology*
Betacoronavirus / pathogenicity
COVID-19
COVID-19 Vaccines
Clinical Trials as Topic
Coronavirus Infections / epidemiology*
Coronavirus Infections / immunology
Coronavirus Infections / prevention & control*
Coronavirus Infections / virology
Databases, Factual
Drug Approval
Humans
Immunogenicity, Vaccine
International Cooperation
Pandemics / prevention & control*
Patient Safety
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / immunology
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / virology
SARS-CoV-2
Vaccination
Viral Vaccines / administration & dosage
Viral Vaccines / biosynthesis*

Substances

COVID-19 Vaccines
Viral Vaccines